FindTrial
Sign In

Sympathectomy versus Conventional treatment for refractory coronary artery spasm

Sympathectomy versus Conventional treatment for refractory coronary artery spasm

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017738
Enrollment
Unknown
Registered
2018-08-11
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory coronary artery spasm

Interventions

surgery group:Sympathectomy
conventional treatment group:no

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic standard of coronary spasm stimulation test; 2. Meet the diagnostic standard of intractable coronary spasm.

Exclusion criteria

Exclusion criteria: In accordance with the 2013 JCS guidelines, patients were excluded if they had percautious coronary intervention (PCI) or coronary artery bypass surgery(CABG) with acute myoinfarction within 30 days. Other exclusion criterias were ICD implantation, an age of more than 80 years, coexisting major stroke with a risk of hemorrhagic transformation at the time of diagnosis, and a serious coexisting condition (e.g.cancer).

Design outcomes

Primary

MeasureTime frame
MACE (including cardiac death, nonfatal myocardial infarction, unstable angina, heart failure and life-threatening arrhythmia);—

Countries

China

Contacts

Public ContactLin Yaowang

Shenzhen People's Hospital

linyw012@163.com+86 15012672199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026